Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer | Zendy

Babs G. Sibinga Mulder | Zendy; J. Sven D. Mieog | Zendy; Arantza Fariña Sarasqueta | Zendy; Henricus J.M. Handgraaf | Zendy; Hans F. A. Vasen | Zendy; RutgerJan Swijnenburg | Zendy; Saskia Luelmo | Zendy; Shirin Feshtali | Zendy; Akin Inderson | Zendy; Alexander L. Vahrmeijer | Zendy; Bert A. Bonsing | Zendy; Tom van Wezel | Zendy; Hans Morreau | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer

Author(s) -

Babs G. Sibinga Mulder,

J. Sven D. Mieog,

Arantza Fariña Sarasqueta,

Henricus J.M. Handgraaf,

Hans F. A. Vasen,

RutgerJan Swijnenburg,

Saskia Luelmo,

Shirin Feshtali,

Akin Inderson,

Alexander L. Vahrmeijer,

Bert A. Bonsing,

Tom van Wezel,

Hans Morreau

Publication year - 2017

Publication title -

journal of clinical pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.1

H-Index - 127

eISSN - 1472-4146

pISSN - 0021-9746

DOI - 10.1136/jclinpath-2017-204607

Subject(s) - periampullary cancer , pancreatic cancer , medicine , bioinformatics , cancer , oncology , biology

Radiological imaging and morphological assessment of cytology material have limitations for preoperative classification of pancreatic or periampullary lesions, often resulting in surgical resection without definitive diagnosis. Our prospective study aims to define the diagnostic value of targeted next-generation sequencing (NGS) of DNA from cytology material.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research